Gymnocarpium robertianum
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Gymnocarpium robertianum |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Gymnocarpium Robertianum |
| Ipni Id | 17112130-1 |
| Plant Name | Gymnocarpium Robertianum |
| Genus Tax Id | 32115 |
| Disease Name | Motor neuron disease, Thyroid cancer, Liver cancer, Angina pectoris, Thrombocytopenia, Myotonic disorder, Low bone mass disorder, BCR-ABL1-negative chronic myeloid leukaemia, Blood-forming organ disease, Bone/articular cartilage neoplasm, Rheumatoid arthritis, Colorectal cancer, Biliary tract cancer, Colon cancer, Acute diabete complication, Duodenal ulcer, Ureteral cancer, Chronic arterial occlusive disease, Acute myeloid leukaemia, Bacterial infection, Retinopathy, Solid tumour/cancer, Alzheimer disease, Thrombosis, Psoriasis, Prostate cancer, Bladder cancer, Urethral cancer, Dyslipidemia, Breast cancer, Metastatic malignant neoplasm, Ovarian cancer, Pain, unspecified, Venous thromboembolism, Liver disease, Malignant haematopoietic neoplasm, Melanoma, Endometrial cancer, Atopic eczema, Pituitary gland disorder, Unspecified viral infection of unspecified site, Seborrhoeic dermatitis, Oesophageal/gastroduodenal disorder, Leiomyosarcoma, Thyrotoxicosis, Essential hypertension, Peroxisomal disease, Multiple myeloma, Irritable bowel syndrome, Asthma, Malignant digestive organ neoplasm, Non-alcoholic fatty liver disease, Multiple sclerosis, Chronic kidney disease, Myelodysplastic syndrome, Stomach cancer, Type 2 diabetes mellitus, Mature B-cell lymphoma, Inflammatory arthropathy, Christmas disease, Non-small cell lung cancer, Pleomorphic sarcoma, Follicular lymphoma, Fungal infection, Cervical cancer, Mastocytosis, Lung cancer, Renal cell carcinoma, Nasopharyngeal cancer, Brain cancer, Transplanted organ/tissue, Mature B-cell leukaemia, Fallopian tube cancer, Unspecific substance harmful effect, Skin and skin-structure infection, Peritoneal cancer, Digestive organ benign neoplasm, Coagulation defect, Synovial sarcoma, Ischemia, Gastrointestinal stromal tumour, Kidney failure, Cardiovascular disease, Pancreatic cancer, Mild neurocognitive disorder, Autism spectrum disorder, Acquired hypermelanosis, Hypopharyngeal cancer, Coronary thrombosis, Substance abuse, Deep vein thrombosis, Unspecific body region injury, Diabetes mellitus, type unspecified, Extraocular muscle disorder, Cushing syndrome, Diffuse large B-cell lymphoma, Chronic myelomonocytic leukaemia, Metastatic lymph node neoplasm, Genetic prion disease, Chronic pain, Female pelvic pain, Metastatic liver/bile duct neoplasm, Ovarian dysfunction, Transplant rejection, Cerebral ischaemia, Encephalopathy, Spinal cord/cranial nerve neoplasm, Parkinsonism, Osteosarcoma, Heart failure, Ischaemic/haemorrhagic stroke, Parasitic infection, Hyperlipidemia, Influenza, Schizophrenia, Diabetic foot ulcer, Dementia, Mineral deficiency, Myeloproliferative neoplasm, Inborn metabolism deficiency, Glaucoma, Cerebral ischaemic stroke, Lip/oral cavity/pharynx neoplasm, Malignant mesenchymal neoplasm, Metabolic disorder, Head and neck cancer, Ocular cancer, Crohn disease, Attention deficit hyperactivity disorder, Inborn purine/pyrimidine/nucleotide metabolism error, Gout, Intracerebral haemorrhage, Choreiform disorder, Epidermal dysplasias, Synthesis disorder, Inborn lipid metabolism error, Parasitic worm infestation, Skin postprocedural disorder, Esophageal cancer, Supraventricular tachyarrhythmia, Hepatitis virus infection, Indeterminate colitis, Idiopathic interstitial pneumonitis, Multiple structural anomalies syndrome, Nutritional deficiency, Bleeding disorder, Carcinoid syndrome, Myasthenia gravis, Autoimmune disease, Insomnia, Phakomatoses/hamartoneoplastic syndrome, Hyper-lipoproteinaemia, Muscular atrophy, Acquired hypomelanotic disorder, Filariasis, Myocardial infarction, Cataract, Testicular cancer, Mature T-cell lymphoma, Neuropathy, Acute/subacute hepatic failure, Endometriosis, Postoperative inflammation, Metastatic digestive system neoplasm, Autonomic nervous system disorder, Liposarcoma, Oesophagitis, Fragile X chromosome, Lupus erythematosus, Metastatic biliary tract neoplasms, Pediculosis, Muscular dystrophy, Coronavirus infection, Ischemic heart disease, Human immunodeficiency virus disease, Unspecified malignant neoplasms of unspecified sites, Neoplasms, Anemia, Tension-type headache, Systemic lupus erythematosus, Severe acute respiratory syndrome, Macular degeneration, COVID-19, Spina bifida, unspecified, Obesity, Cleft palate, Noninfectious erosive or ulcerative disorders of oral mucosa, Peripheral T-cell lymphoma, not otherwise specified, coronary artery disease, Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language, Male infertility, Chronic obstructive pulmonary disease, Malaria, Carpal tunnel syndrome, Cleft lip, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Cutaneous T-cell lymphoma, NOS, Ageing associated decline in intrinsic capacity, Recurrent pregnancy loss, Pulmonary hypertension, Osteoarthritis of knee, Chronic hepatitis C, Schizophrenia or other primary psychotic disorders, unspecified, Osteoarthritis, Sezary syndrome, Other specified infectious meningitis not elsewhere classified, Ischaemic heart diseases, unspecified, Gastro-oesophageal reflux disease, Harmful effects of drugs, medicaments or biological substances, not elsewhere classified, Cholelithiasis, Neoplasms of unknown behaviour of breast, Oral mucositis, Kidney failure, unspecified, Breast in situ carcinoma, Lichen planus, Sickle-cell disorder, HIV-infected patients with tuberculosis, Coronary atherosclerosis, Malignant neoplasms of retroperitoneum, Epilepsy/seizure, Rectum cancer, Adenocarcinoma of prostate, Malignant neoplasms of other or unspecified parts of mouth, Anaplastic large cell lymphoma, NOS, Nephrocalcinosis, Cystic fibrosis, Depressive disorders, unspecified, Becker muscular dystrophy, Haemorrhage, not elsewhere classified, Focal/segmental autonomic disorder, Iron deficiency anaemia, Polycystic ovary syndrome, Glioma, malignant, Pleural mesothelioma, Porokeratoses, Disorders of cholesterol synthesis, Mycosis fungoides, Type1diabetesmellitus, Congenital aplastic anaemia, Chronic kidney disease, stage unspecified, Anterior uveitis, Pulmonary alveolar proteinosis, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Inflammatory bowel diseases, unspecified, Zika virus disease, Osteoarthritis, unspecified, Dengue fever, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Malignant neoplasms of bladder, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Pneumonia due to Pseudomonasaeruginosa, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Systemic sclerosis, Chronic rhinosinusitis, Malignant neoplasms of thyroid gland, unspecified, Malignant neoplasms of stomach, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Dilated cardiomyopathy, Malignant neoplasms of thymus, Invasive carcinoma of breast, Heart failure, unspecified, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Ebola virus disease, Malignant neoplasms of adrenal gland, Malignant neoplasm of pancreas, Lyme borreliosis, Gliomas of brain |
| Species Name | Gymnocarpium robertianum |
| Genus Name | Gymnocarpium |
| Species Tax Id | 983334 |
| Disease Id | 8B60, 2D10, 2C12, BA40, 3B64, 8C71, FB83, 2A41, 3C0Z, 2F7B, FA20, 2B91, 2C17, 2B90, 5A2Y, DA63, 2C92, BD4Z, 2A60, 1A00-1C4Z, 9B71, 2A00-2F9Z, 8A20, DB61-GB90, EA90, 2C82, 2C94, 2C93, 5C80-5C81, 2C60-2C6Y, 2D50-2E09, 2C73, MG3Z, BD72, DB90-DB9Z, 2B33, 2C30, 2C76, EA80, 5A60-5A61, 1D9Z, EA81, DD90, 2B58, 5A02, BA00, 5C57, 2A83, DD91, CA23, 2C11, DB92, 8A40, GB61, 2A37, 2B72, 5A11, 2A85, FA2Z, 3B11, 2C25, 2B54, 2A80, 1F29-1F2F, 2C77, 2A21, 2C90, 2B6B, 2A00, QB63, 2A82, 2C74, NE6Z, 1F28-1G0Z, 2C51, 2.00E+92, 3B10, 2B5A, 8B10-8B11, 2B5B, GB60-GB6Z, BA00-BE2Z, 2C10, 6D71, 6A02, ED60, 2B6D, BA43, 6C40, BD71, ND56, 5A14, 9C82, 5A70, 2A81, 2A40, 2D60, 8.00E+02, MG30, GA34, 2D80, 5A80, NE84, 8B1Z, 8.00E+47, 2A02, 8A00, 2B51, BD10-BD1Z, 8B20, 1D0Y-1G2Z, 5C80, 1E30-1E32, 6A20, BD54, 6D80-6D8Z, 5B5K, 2A20, 5C50-5C59, 9C61, 8B11, 2B6E, 2B5D-2B5Y, 5C50-5D2Z, 2D42, 2D00-2D07, DD70, 6A05, 5C55, FA25, 8B00, 8A01, EK90, 5C52-5C59, 5C52, 1F90, EL8Y, 2B70, BC81, 1E50-1E51, DD72, CB03, LD2F, 5B50-5B71, GA20-GA21, 5B10, 8C6Y, 4A40-4A45, 7A00-7A0Z, LD2D, 8B61, ED63, 1F66, BA41-BA43, 9B10, 2C80, 2A90, 8C0Z, DB91, GA10, 1A00-CA43, 2D8Y, 8D87, 2B59, DA24, LD55, 4A40, 2C14-2C17, 1G00, 8C70, 1D92, BA40-BA6Z, 1C60-1C62, 2D4Z, 2, 3A00-3A9Z, 8A81, 4A40.0, 1D65, 9B75, 1D6Y, LA02.Z, 5B80-5B81, LA42, DA01.1, 2A90.C, BA8Y-BA8Z, 6A02.0, GB04, CA22, 1F40-1F45, 8C10.0, LA40, 1C62.Z, XH1951, MG2A, GA33, BB01, FA01, 1E51.1, 6A2Z, FA00-FA05, XH8HN3, 1D01.Y, BA6Z, DA22, NE60, DC11, 2F95, DA01, GB6Z, 2.00E+65, EA91, 3A51, 1B10-1B14, BA80, 2C50, 8A61-8A6Z, 2B92, 2C82.0, 2B66, XH1LC0, GB57, CA25, 6A7Z, 8C70.0, MG27, 8D8A, 3A00, 5A80.1, XH4RQ3, 2C26, ED52, 5C52.10, 2B01, 5A10, 3A70.0, GB61.Z, 9A96, CB04.31, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, DD7Z, 1D48, FA0Z, 1D2Z, 2C15, 2C12.01, 1F54, 2B72.0, BC81.3, 2D60.0, 8C71.0, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, CA40.05, 2C12.02, 2C25.Y, GA10.B4, 2C94.2, 1D82, 4A42, CA0A, 2D10.Z, 2C25.0, 2C76.Z, 1D40, BC43.0, 2C27, 2C61, BD1Z, 1C62, 2A00.00, XH6153, 2C80.2, 1D60.01, 2D11, 1C1G, 2A00.0 |
| Family Name | Cystopteridaceae |
| Family Tax Id | 1203500 |
- 1. (-)-Epitaxifolin (PubChem CID: 712318)
- 2. (1r,3r,6s,8r,11s,12r,15r,16r)-7,7,11,12,16-Pentamethyl-15-[(2s)-6-Methylhept-5-En-2-Yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 162905452)
- 3. (1r,3s,6s)-6-[(1e,3e,5e,7z,9e,11e,13e,15e,17e)-18-[(1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-Nonaenyl]-1,5,5-Trimethyl-7-Oxabicyclo[4.1.0]heptan-3-Ol (PubChem CID: 12358665)
- 4. (1s)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1r,4s)-4-Hydroxy-2,6,6-Trimethylcyclohex-2-En-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-Nonaenyl]-3,5,5-Trimethylcyclohex-3-En-1-Ol (PubChem CID: 44481270)
- 5. (1s,2r,4as,6ar,6ar,6br,8ar,10s,12ar,14ar,14bs)-1,2,4a,6a,6b,9,9,12a-Octamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14,14a,14b-Hexadecahydropicene-2,10-Diol (PubChem CID: 10478653)
- 6. (1s,2s,4as,6ar,6ar,6br,8ar,10s,12ar,14ar,14bs)-1,2,4a,6a,6b,9,9,12a-Octamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14,14a,14b-Hexadecahydropicene-2,10-Diol (PubChem CID: 14313598)
- 7. (1s,3r,6s)-6-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1r,4s,6s)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-Nonaenyl]-1,5,5-Trimethylcyclohexane-1,3-Diol (PubChem CID: 162989145)
- 8. (1s,3r,6s,7s,8s,11s,12s,15r,16r)-7-(Hydroxymethyl)-7,12,16-Trimethyl-15-[(2r)-6-Methylheptan-2-Yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 163093755)
- 9. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r)-6-(Hydroxymethyl)hept-6-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 163034995)
- 10. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r,5r)-5-Hydroxy-6-Methylhept-6-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 14313591)
- 11. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2s,3r)-3-Hydroxy-6-Methylhept-5-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 163025603)
- 12. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(E,2r)-6-Methoxy-6-Methylhept-4-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 21599950)
- 13. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(E,2r,6r)-7-Hydroxy-6-Methylhept-4-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 162945131)
- 14. (1s,3r,6s,8s,11r,12s,15r,16r)-15-[(2s,6s)-7-Hydroxy-6-Methyl-5-Methylideneheptan-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 162877130)
- 15. (1s,3r,8r,11s,12s,15r,16r)-15-[(2r,6s)-7-Hydroxy-6-Methyl-5-Methylideneheptan-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-One (PubChem CID: 100966504)
- 16. (1s,3r,8s,11s,12s,13s,15r,16r)-7,7,13,16-Tetramethyl-15-[(2r)-6-Methylhept-5-En-2-Yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecane (PubChem CID: 162959957)
- 17. (24s)-Cycloartane-3 (PubChem CID: 14314549)
- 18. (2r)-2,3-Dihydroxypropyl (9z)-Octadec-9-Enoate (PubChem CID: 11451146)
- 19. (2r,3r)-2-(3,4-Dihydroxyphenyl)-3,4-Dihydro-5,7-Dihydroxy-2h-1-Benzopyran-3-Yl Beta-D-Glucopyranoside (PubChem CID: 21626710)
- 20. (2r,3s)-2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-[(2r,3s,4r,5r,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-2,3-Dihydrochromen-4-One (PubChem CID: 162993993)
- 21. (2r,3s,4s,5r,6r)-2-(Hydroxymethyl)-6-[(1r,6s)-6-Nonylcyclohex-2-En-1-Yl]oxyoxane-3,4,5-Triol (PubChem CID: 162937063)
- 22. (2r,6r)-2-Methyl-3-Methylidene-6-[(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]heptanoic Acid (PubChem CID: 101286242)
- 23. (2r,6r)-6-[(1r,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methyl-3-Methylideneheptanoic Acid (PubChem CID: 163038821)
- 24. (2r,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methyl-3-Methylideneheptanoic Acid (PubChem CID: 101286241)
- 25. (2r,6s)-2-Methyl-3-Methylidene-6-[(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]heptanoic Acid (PubChem CID: 163011701)
- 26. (2r,6s)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methyl-3-Methylideneheptanoic Acid (PubChem CID: 163038823)
- 27. (2r,6s,10s)-2,6,10-Trimethyldodecanoic Acid (PubChem CID: 162960174)
- 28. (2r,6s,7ar)-2-[(2e,4e,6e,8e,10e,12e,14e,16e)-17-[(1s,4r,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]-6,11,15-Trimethylheptadeca-2,4,6,8,10,12,14,16-Octaen-2-Yl]-4,4,7a-Trimethyl-2,5,6,7-Tetrahydro-1-Benzofuran-6-Ol (PubChem CID: 162861646)
- 29. (2r,7ar)-4,4,7a-Trimethyl-2-[(2e,4e,6e,8e,10e,12e,14e,16e)-6,11,15-Trimethyl-17-(2,6,6-Trimethylcyclohexen-1-Yl)heptadeca-2,4,6,8,10,12,14,16-Octaen-2-Yl]-2,5,6,7-Tetrahydro-1-Benzofuran (PubChem CID: 163004300)
- 30. (2s)-2-[[4-[(2-Amino-4-Oxo-1h-Pteridin-6-Yl)methylamino]benzoyl]amino]pentanedioic Acid (PubChem CID: 6037)
- 31. (2s,3r,4s,5s,6r)-3,5-Dimethoxy-6-(Methoxymethyl)oxane-2,4-Diol (PubChem CID: 13887303)
- 32. (2s,3r,4s,5s,6r)-6-(Hydroxymethyl)-3,4-Dimethoxyoxane-2,5-Diol (PubChem CID: 163044429)
- 33. (2s,4r,10s)-2,10-Dimethyl-6-Methylidenedodecane-1,4-Diol (PubChem CID: 162934688)
- 34. (2s,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methyl-3-Methylideneheptanoic Acid (PubChem CID: 163185187)
- 35. (3,4-Dihydroxyphenyl)[2,4,6-Trihydroxy-3-[2,3,6-Tris-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 101352486)
- 36. (3,4-Dihydroxyphenyl)[2,4,6-Trihydroxy-3-[2-O-(4-Hydroxybenzoyl)-6-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 102076688)
- 37. (3,4-Dihydroxyphenyl)[2,4,6-Trihydroxy-3-[6-O-(4-Hydroxybenzoyl)-2-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 102076687)
- 38. (3,4-Dihydroxyphenyl)[2,4,6-Trihydroxy-3-[6-O-(4-Hydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 163052741)
- 39. (3r,4ar,6ar,6br,8ar,12as,14as,14br)-4,4,6a,6b,8a,11,11,14b-Octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-Tetradecahydropicen-3-Ol (PubChem CID: 163069310)
- 40. (3r,5r)-5-[(2r)-2,6-Dimethylheptyl]-3-Ethyloxolan-2-One (PubChem CID: 162996247)
- 41. (3s)-Beta-Cryptoxanthin (PubChem CID: 44554791)
- 42. (3s,3as,5ar,5br,7as,9s,11r,11ar,11bs,13ar,13bs)-3-(2-Hydroxypropan-2-Yl)-5a,5b,8,8,11a,13b-Hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-Hexadecahydrocyclopenta[A]chrysene-9,11-Diol (PubChem CID: 14314555)
- 43. (3s,4ar,6ar,6bs,8ar,11r,12s,12as,14ar,14br)-4,4,6a,6b,8a,11,12,14b-Octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-Tetradecahydro-1h-Picen-3-Ol (PubChem CID: 10836206)
- 44. (3s,4ar,6ar,6bs,8ar,12as,14ar,14br)-4,4,6a,6b,8a,11,11,14b-Octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-Tetradecahydropicen-3-Ol (PubChem CID: 12358398)
- 45. (3s,5r,9r,10s,13r,14r,17r)-17-[(2r,5r)-5-Ethyl-6-Methylheptan-2-Yl]-3-Hydroxy-10,13-Dimethyl-1,2,3,4,5,6,9,12,14,15,16,17-Dodecahydrocyclopenta[A]phenanthren-11-One (PubChem CID: 162992686)
- 46. (4-Hydroxyphenyl)[2,4,6-Trihydroxy-3-[2,3,6-Tris-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 162986904)
- 47. (4ar,6ar,6ar,6br,8as,11r,12s,12ar,14ar,14br)-11-Hydroxy-4,4,6a,6b,8a,11,12,14b-Octamethyl-2,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-Tetradecahydro-1h-Picen-3-One (PubChem CID: 162959924)
- 48. (4ar,6ar,6ar,6br,8as,11s,12s,12as,14ar,14br)-11-Hydroxy-4,4,6a,6b,8a,11,12,14b-Octamethyl-2,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-Tetradecahydro-1h-Picen-3-One (PubChem CID: 101290252)
- 49. (4ar,6ar,6as,6br,8ar,10r,12ar,14br)-10-Hydroxy-2,2,6a,6b,9,9,12a-Heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-Tetradecahydropicene-4a-Carbaldehyde (PubChem CID: 162939236)
- 50. (4ar,6as,6ar,6br,8ar,11r,12s,12ar,14ar,14br)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,4a,5,6,6a,7,8,9,10,11,12,12a,13,14,14a-Hexadecahydropicen-3-One (PubChem CID: 15427884)
- 51. (4ar,6as,6ar,6br,8as,11r,12r,12as,14ar,14br)-11-Hydroxy-4,4,6a,6b,8a,12,14b-Heptamethyl-1,2,4a,5,6,6a,7,8,9,10,11,12,12a,13,14,14a-Hexadecahydropicen-3-One (PubChem CID: 162962891)
- 52. (5r,8r,9r,10r,13r,14r,17s)-17-[(2s,5r)-5-[(2s)-1,2-Dihydroxypropan-2-Yl]-2-Methyloxolan-2-Yl]-4,4,8,10,14-Pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-One (PubChem CID: 162995360)
- 53. (5r,8r,9s,10r,13r,14r,17s)-17-[(2r,5r)-5-[(2s)-1,2-Dihydroxypropan-2-Yl]-2-Methyloxolan-2-Yl]-4,4,8,10,14-Pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-One (PubChem CID: 162995359)
- 54. (5s,6r)-Beta-Carotene 5,6-Epoxide (PubChem CID: 9548874)
- 55. (6r)-6-[(1s,3r,6r,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162956741)
- 56. (E,4r,6r)-4-Hydroxy-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 100966505)
- 57. (E,4s,6r)-4-Hydroxy-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 100966506)
- 58. (E,5r,6s)-5-Hydroxy-6-[(1s,3r,6r,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162937479)
- 59. (E,5r,6s)-5-Hydroxy-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162937480)
- 60. (E,6r)-2-(Hydroxymethyl)-6-[(1s,3r,6r,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-Enoic Acid (PubChem CID: 14314564)
- 61. (E,6r)-2-Methyl-6-[(1s,3r,8r,11s,12s,13s,15r,16r)-7,7,13,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-Enoic Acid (PubChem CID: 162939569)
- 62. (E,6r)-2-Methyl-6-[(1s,3r,8s,11s,12s,15r,16r)-7,7,12,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-Enoic Acid (PubChem CID: 14034475)
- 63. (E,6r)-6-[(1s,3r,6s,8r,11s,12s,13s,15r,16r)-6-Hydroxy-7,7,13,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162945699)
- 64. (E,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enal (PubChem CID: 14314541)
- 65. (E,6r)-6-[(1s,3r,6s,8s,11r,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enal (PubChem CID: 162961000)
- 66. (E,6s)-2-Methyl-6-[(1s,3r,8s,11s,12s,15r,16r)-7,7,12,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-Enoic Acid (PubChem CID: 163065451)
- 67. (E,6s)-6-[(1s,3r,6r,8s,11r,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162956738)
- 68. (Z)-5-(Heptadec-2-En-1-Yl)resorcinol (PubChem CID: 126457709)
- 69. 1,3,6,7-Tetrahydroxy-2-[(2r,3s,4s,5r,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]xanthen-9-One (PubChem CID: 124461561)
- 70. 1,3,6,7-Tetrahydroxy-2-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyxanthen-9-One (PubChem CID: 5319258)
- 71. 1,3,6,7-Tetrahydroxy-4-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyxanthen-9-One (PubChem CID: 162901555)
- 72. 1,3-Dielaidin (PubChem CID: 5316908)
- 73. 1,6,7-Trihydroxy-3-Methoxy-2-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyxanthen-9-One (PubChem CID: 5318081)
- 74. 2,3,4,6-Tetra-O-Methyl-Alpha-D-Glucose (PubChem CID: 111162)
- 75. 2,3,6-Tri-O-Methyl-Beta-D-Glucopyranose (PubChem CID: 448683)
- 76. 2,3-Di-O-Methyl-Alpha-D-Glucopyranose (PubChem CID: 14211992)
- 77. 2-Monoolein (PubChem CID: 5319879)
- 78. 24-Methylenecycloartanol (PubChem CID: 94204)
- 79. 24-Methylenecycloartanone (PubChem CID: 14635659)
- 80. 27-Hydroxymangiferolic Acid (PubChem CID: 45269256)
- 81. 27-Hydroxymangiferonic Acid (PubChem CID: 45270932)
- 82. 28-Hydroxymangiferonic Acid (PubChem CID: 45270931)
- 83. 3,4-Dihydroxybenzoic Acid (PubChem CID: 72)
- 84. 3-[(2r,3s,4r,5s,6s)-3,5-Dihydroxy-6-(Hydroxymethyl)-4-[(2s,3s,4r,5r,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyoxan-2-Yl]oxy-2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxychromen-4-One (PubChem CID: 163043399)
- 85. 3-[3,4-Dihydroxy-5-(3,4,5-Trihydroxyphenoxy)carbonylbenzoyl]oxy-4,5-Dihydroxybenzoic Acid (PubChem CID: 162974772)
- 86. 3-Hydroxy-4-Methyl-5-(3,4,5-Trihydroxybenzoyl)oxybenzoic Acid (PubChem CID: 163047252)
- 87. 5-((8z,11z)-Heptadeca-8,11-Dien-1-Yl)resorcinol (PubChem CID: 14235913)
- 88. 5-(Heptadec-12-Enyl)resorcinol (PubChem CID: 5281859)
- 89. 5-[(E)-Heptadec-12-Enyl]benzene-1,3-Diol (PubChem CID: 5318012)
- 90. 5-[(Z)-Heptadec-11-Enyl]benzene-1,3-Diol (PubChem CID: 24802634)
- 91. 5-Hydroxy-3-(4-Hydroxylphenyl)pyrano[3,2-G]chromene-4(8h)-One (PubChem CID: 91356749)
- 92. 6beta-Hydroxystigmast-4-En-3-One (PubChem CID: 9823926)
- 93. 9,19-Cyclolanost-24-Ene-3,26-Diol, (3beta)- (PubChem CID: 134694294)
- 94. 9,19-Cyclolanostan-28-Ol, (4beta)- (PubChem CID: 101670839)
- 95. 9,19-Cyclolanostan-3-One, 26-Hydroxy-24-Methylene-, (25r)- (PubChem CID: 162891806)
- 96. 9-Cis-Violaxanthin (PubChem CID: 5282218)
- 97. [(2s,3r,4s,5r,6s)-2-[3-(3,4-Dihydroxybenzoyl)-2,4,6-Trihydroxyphenyl]-4,5-Dihydroxy-6-[(4-Hydroxybenzoyl)oxymethyl]oxan-3-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162871723)
- 98. [(3s,5r,8r,9s,10s,13r,14s,17r)-9-Ethyl-4,4,13,14-Tetramethyl-17-[(2r)-6-Methylheptan-2-Yl]-2,3,5,6,7,8,10,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl] Acetate (PubChem CID: 162960071)
- 99. [2,6-Dihydroxy-4-Methoxy-3-[(2s,3r,4r,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]phenyl]-(4-Hydroxy-3-Methoxyphenyl)methanone (PubChem CID: 46206549)
- 100. [2,6-Dihydroxy-4-Methoxy-3-[(2s,3r,4r,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]phenyl]-(4-Hydroxyphenyl)methanone (PubChem CID: 46206548)
- 101. [3-[2,6-Bis-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]-2,4,6-Trihydroxyphenyl](4-Hydroxyphenyl)methanone (PubChem CID: 102082135)
- 102. Alpha-Amyrin (PubChem CID: 73170)
- 103. Alpha-D-Galactose (PubChem CID: 439357)
- 104. Alpha-Methylbutyrolactone, (R)- (PubChem CID: 638758)
- 105. Arachidic Acid (PubChem CID: 10467)
- 106. Aubergenone (PubChem CID: 15601418)
- 107. Aurasperone D (PubChem CID: 155008)
- 108. Beta-Amyrin (PubChem CID: 73145)
- 109. Beta-Carotene (PubChem CID: 5280489)
- 110. Beta-Sitosterol (PubChem CID: 222284)
- 111. Cholesterol (PubChem CID: 5997)
- 112. Cianidanol (PubChem CID: 9064)
- 113. Cycloart-23-Ene-3beta,25-Diol (PubChem CID: 5470009)
- 114. Cycloart-23-Ene-3i(2),25-Diol (PubChem CID: 393626)
- 115. Cycloartane-3i(2),25-Diol (PubChem CID: 14314547)
- 116. Cycloartenol (PubChem CID: 92110)
- 117. Cycloartenol Acetate (PubChem CID: 13023741)
- 118. Cycloartenone (PubChem CID: 12305360)
- 119. Dammar-24-En-3-One, 20,26-Dihydroxy-, (24e)- (PubChem CID: 162968264)
- 120. Dammarenediol-I (PubChem CID: 441675)
- 121. Diolein (PubChem CID: 6505653)
- 122. Epicatechin (PubChem CID: 72276)
- 123. Epifriedelanol (PubChem CID: 119242)
- 124. Epigallo Catechin Gallate (PubChem CID: 5276454)
- 125. Erythrodiol (PubChem CID: 101761)
- 126. Ethyl Gallate (PubChem CID: 13250)
- 127. Euxanthone (PubChem CID: 5281631)
- 128. Fisetin (PubChem CID: 5281614)
- 129. Friedelin (PubChem CID: 91472)
- 130. Friedelinol (PubChem CID: 101341)
- 131. Gallic Acid (PubChem CID: 370)
- 132. Gentisein (PubChem CID: 5281635)
- 133. Heptadecanoic Acid (PubChem CID: 10465)
- 134. Hexacontane (PubChem CID: 24318)
- 135. Homomangiferin (PubChem CID: 5491388)
- 136. Hydrogen Cyanide (PubChem CID: 768)
- 137. Isomangiferin (PubChem CID: 5318597)
- 138. Isomangiferolic Acid (PubChem CID: 14034468)
- 139. Isoschisandrolicacid (PubChem CID: 137347660)
- 140. Kaempferol (PubChem CID: 5280863)
- 141. L-Tartaric Acid (PubChem CID: 444305)
- 142. Linoleic Acid (PubChem CID: 5280450)
- 143. Linolenic Acid (PubChem CID: 5280934)
- 144. Lupeol (PubChem CID: 259846)
- 145. Lupeol Acetate (PubChem CID: 92157)
- 146. Maclurin 3-C-Beta-Glucoside (PubChem CID: 101538363)
- 147. Mangiferin (PubChem CID: 5281647)
- 148. Mangiferin 6'-O-Gallate (PubChem CID: 162932599)
- 149. Mangiferolic Acid (PubChem CID: 45270099)
- 150. Mangiferonic Acid (PubChem CID: 14034474)
- 151. Methyl Gallate (PubChem CID: 7428)
- 152. Myristic Acid (PubChem CID: 11005)
- 153. Norathyriol (PubChem CID: 5281656)
- 154. Olean-13(18)-En-11-One (PubChem CID: 15427883)
- 155. Oleanolic Aldehyde (PubChem CID: 10321055)
- 156. Oleic Acid (PubChem CID: 445639)
- 157. Palmitic Acid (PubChem CID: 985)
- 158. Pentadecanoic Acid (PubChem CID: 13849)
- 159. Pentagalloylglucose (PubChem CID: 65238)
- 160. Propyl Benzoate (PubChem CID: 16846)
- 161. Propyl Gallate (PubChem CID: 4947)
- 162. Quercetin (PubChem CID: 5280343)
- 163. Quercitrin (PubChem CID: 5280459)
- 164. Quosp (PubChem CID: 5282166)
- 165. Rhamnetin 3-Galactoside (PubChem CID: 10344991)
- 166. Rhamnetin 3-O- (PubChem CID: 14704554)
- 167. Rubrofusarin (PubChem CID: 72537)
- 168. Rutin (PubChem CID: 5280805)
- 169. Sitogluside (PubChem CID: 5742590)
- 170. Stearic Acid (PubChem CID: 5281)
- 171. Stigmastane-3,6-Diol (PubChem CID: 12070151)
- 172. Taraxerol (PubChem CID: 92097)
- 173. Taraxerone (PubChem CID: 92785)
- 174. Triacontane (PubChem CID: 12535)
- 175. Zeaxanthin, (3s,3's)- (PubChem CID: 21772452)
- 1. Alzheimer's Disease 1
- 2. Anemia
- 3. Arthritis
- 4. Arthritis, Gouty
- 5. Arthritis, Rheumatoid
- 6. Asthma
- 7. Cardiovascular Diseases
- 8. Cataract
- 9. Celiac Disease
- 10. Cholelithiasis
- 11. Cholera
- 12. Coronary Artery Disease
- 13. Crohn Disease
- 14. Cystic Fibrosis
- 15. Dementia
- 16. Diabetes Mellitus
- 17. Diabetes Mellitus, Type 1
- 18. Epilepsy
- 19. Esophagitis
- 20. Filariasis
- 21. Glaucoma
- 22. Hematologic Diseases
- 23. Infertility, Male
- 24. Inflammatory Bowel Diseases
- 25. Influenza, Human
- 26. Liver Neoplasms
- 27. Lupus Erythematosus, Systemic
- 28. Muscular Dystrophies
- 29. Myocardial Infarction
- 30. Obesity
- 31. Osteoarthritis
- 32. Pre-Eclampsia
- 33. Psoriasis
- 34. Scleroderma, Systemic
- 35. Stomatitis
- 36. Thrombocytopenia
Not listed in any formulations.